European Archives - Page 559 of 1108 - European Medical Journal

Rheumatology Feature Image

EMJ Rheumatology 8.1 2021

Welcome to the latest issue of EMJ Rheumatology! We are pleased to share with you a collection of the latest rheumatology insights, peer-reviewed research, and exclusive interviews with experts in the field, alongside our review of the European League Against Rheumatism (EULAR) Congress 2021 with research updates and news from the virtual event.

Rheumatology Feature Image

Review of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress

Virtual again… once more the European Alliance of Associations for Rheumatology (EULAR) took the decision to hold their prestigious annual…

Rheumatology Feature Image

Artificial Intelligence in Rheumatic Diseases: Can It Solve the Treatment Management Puzzle?

This symposium was developed to consider the future role that AI might play in the management of rheumatic diseases. First, Ignacio Medrano considered the current use of AI in healthcare and its possible future applications.

Managing Chronic Pain in Osteoarthritis and Rheumatoid Arthritis

ON DAY 3 of the European Alliance of Associations for Rheumatology (EULAR) 2021 Congress, participants from across the globe accessed the virtual platform to join Jon Lampa, Associate Professor, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, and his panel as they explored the challenges and opportunities of managing chronic pain in osteoarthritis and rheumatoid arthritis.

Mind the Gap: Balancing Remission and Risk of Relapse in ANCA-Associated Vasculitis

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an umbrella term for a group of rare, multisystem autoimmune…

Rheumatology Feature Image

Association Between Environmental Air Pollution and Rheumatoid Arthritis Flares

Environmental air pollution has been linked to the pathogenesis of rheumatoid arthritis (RA).1 Nevertheless, there is no evidence linking higher concentrations of air pollutants with the risk of RA reactivations.

Striking the Right Balance in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis

AAV are a type of small-vessel necrotising vasculitis that manifest as systemic diseases, with pulmonary; ear, nose, and throat; and renal involvement. The key pathological feature of AAV is the presence of ANCA, which can target two neutrophil antigens, myeloperoxidase (MPO) and proteinase 3 (PR3).

Rheumatology Feature Image

Efficacy and Safety of TNF-α Antagonists and Tocilizumab in Takayasu Arteritis: Multi-centre, Retrospective Study of 209 Patients

Takayasu arteritis (TA) is a chronic inflammatory large-vessel vasculitis, predominantly affecting the aorta and its main branches.

EULAR Interview: Joan Bathon

Joan Bathon | Member of the EULAR Scientiﬁc Programme Committee; Director of the Division of Rheumatology at New York-Presbyterian Hospital…

Interview: Christopher Edwards

Christopher Edwards | Professor and Consultant Rheumatologist and Honorary Chair of Clinical Rheumatology; Musculoskeletal Research Unit…